Today we travelled to Kobe to visit the Foundation for Biomedical Research and Innovation at Kobe (FBRI).
The cluster at Kobe has grown dramatically recently with several hundred companies and hospital buildings all residing on an artificial island that was built after an earthquake devastated Kobe in 1995.
They’re working to help build collaborations between academia, industry and clinicians and are one of the first places in the world to treat patients with regenerative medicine for AMD (age-related macular degeneration) and CAR-T therapy.
We were given a tour of the Translational Research building before attending the ‘latest trends in advanced therapy and biomedical engineering’ seminar which brought together UK and Japanese speakers.
It was interesting to see both the cutting-edge science taking place, but also that the Japanese are facing the same challenges we face to break down silos, create collaborative partnerships and speed up the translation of innovation from the lab to patients.
We had a great time and met several interesting companies. It was fantastic to stand in a thriving life sciences area of so many companies and healthcare provider buildings that 20 years ago wasn’t even an island, but just the sea!
Related News Articles
Dr Ben Martyn blogs from Tokyo where he and Keith Miller, the NHSA’s Head of Corporate Engagement, spent the second day of the UK trade mission.Read the article
A blog from the new CEO Dr Séamus O’Neill as he takes up the NHSA Chief Executive roleRead the article
Why we should stop at nothing to turn the North into the healthiest place to live and enjoy the economic benefits that will bring, by Dr Ben MartynRead the article